Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) FCF Margin % : -16.48% (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Parnell Pharmaceuticals Holdings's Free Cash Flow for the six months ended in Dec. 2018 was $-3.14 Mil. Parnell Pharmaceuticals Holdings's Revenue for the six months ended in Dec. 2018 was $19.03 Mil. Therefore, Parnell Pharmaceuticals Holdings's FCF Margin % for the quarter that ended in Dec. 2018 was -16.48%.

As of today, Parnell Pharmaceuticals Holdings's current FCF Yield % is 0.00%.

The historical rank and industry rank for Parnell Pharmaceuticals Holdings's FCF Margin % or its related term are showing as below:

PARNF' s FCF Margin % Range Over the Past 10 Years
Min: -16.48 Med: 0 Max: 0
Current: -16.48

PARNF's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.2 vs PARNF: -16.48

Parnell Pharmaceuticals Holdings FCF Margin % Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings FCF Margin % Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

FCF Margin %

Get a 7-Day Free Trial

-136.64

-130.53

-90.28

-22.94

-16.48

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
FCF Margin %	Get a 7-Day Free Trial			-136.64	-130.53	-90.28	-22.94	-16.48

Competitive Comparison of Parnell Pharmaceuticals Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's FCF Margin % falls into.

Parnell Pharmaceuticals Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Parnell Pharmaceuticals Holdings's FCF Margin for the fiscal year that ended in Dec. 2018 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2018 )	/	Revenue (A: Dec. 2018 )
	=	-3.137	/	19.031
	=	-16.48 %

Parnell Pharmaceuticals Holdings's FCF Margin for the quarter that ended in Dec. 2018 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2018 )	/	Revenue (Q: Dec. 2018 )
	=	-3.137	/	19.031
	=	-16.48 %

Parnell Pharmaceuticals Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.